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ABSTRACT
A multiplex PCR with four primer-pairs was
designed to identify the ﬁve main known SCCmec
types. A clear and easily discriminated band
pattern was obtained for all ﬁve types. The
SCCmec type was identiﬁed for 98% of 312
clinical isolates of methicillin-resistant Staphylo-
coccus aureus (MRSA). SCCmec type IV was by far
the most common SCCmec type among both
hospital- and community-acquired MRSA isolates
in Denmark.
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The worldwide increase in the number of infec-
tions caused by methicillin-resistant Staphylococcus
aureus (MRSA) has emphasised the need for fast
and reliable identiﬁcation and typing methods. In
addition to genotyping, characterisation of the
staphylococcal cassette chromosome (SCC) mec
type has led to better discrimination of hospital-
acquired MRSA (HA-MRSA) and community-
onset MRSA (CO-MRSA) [1–5]. The multiplex
PCR for discrimination of SCCmec types I–IV
developed by Oliveira and de Lencastre [6] has
been used widely, but was designed primarily to
characterise HA-MRSA carrying SCCmec types
I–III. Currently, an increase in CO-MRSA is
occurring worldwide, caused mainly by
CO-MRSA belonging to the same multilocus
sequence type lineage as HA-MRSA and carrying
the smaller SCCmec types IV or V [2–4,7]. In order
to discriminate the classic (HA-)MRSA with
SCCmec types I–III from (CO-)MRSA with
SCCmec types IV and V, the present study
developed a new multiplex PCR for use in routine
SCCmec type determinations.
In total, 312 clinical isolates of MRSA from
hospitalised patients or patients attending general
practitioners during 2003–2005 (one isolate per
patient) were used to test the multiplex PCR. The
isolates were all mecA-positive by PCR [6] (results
not shown). Four primer sets were designed to
ensure ampliﬁcation of two DNA targets from
SCCmec type IV and two targets from SCCmec
type V. The targets were chosen so that one target
would be ampliﬁed from each of SCCmec types
I–III (Table 1). To validate the multiplex PCR
method, 50 isolates were also ampliﬁed using the
multiplex PCR of Oliveira and de Lencastre [6].
SCCmec type I isolates were also retested by ccrA1
PCR [8], and SCCmec type II and III isolates were
retested by mecI PCR [6]. PCR was performed in a
total volume of 50 lL containing 1 · AmpliTaq
PCR buffer, 1.5 mM MgCl2, 200 lM each dNTP
and 1 U of AmpliTaq DNA polymerase. Based on
optimisation experiments, primer concentrations
were as follows: primers b and a3, 0.2 lM each;
ccrCF and ccrCR, 0.25 lM each; 1272F1 and
1272R1, 0.08 lM each; and 5RmecA and 5R431,
0.1 lM each. Ampliﬁcation comprised 4 min at
94C, followed by 30 cycles of 30 s at 94C, 30 s at
55C and 60 s at 72C, with a ﬁnal extension for
4 min at 72C. PCR products (5 lL) were analysed
by electrophoresis on agarose 1.5% w ⁄ v gels,
followed by staining with ethidium bromide. The
SCCmec type was determined on the basis of the
band pattern obtained (Table 1; Fig. 1). Isolates
with no visible bands, or with a band pattern that
was not in agreement with one of the ﬁve
predicted band patterns, were classiﬁed as non-
typeable (NT).
A clear and easily discriminated band pattern
was obtained for all ﬁve of the main SCCmec
types using the multiplex PCR (Fig. 1). The
presence of SCCmec types I–III, which yielded
only one band in the multiplex PCR, was con-
ﬁrmed by the additional PCRs described above.
The 50 isolates tested by the multiplex PCR of
Oliveira and de Lancastre [6] yielded results that
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agreed with those obtained by the new method
described above, although, as expected, SCCmec
type V was not identiﬁed by the method of
Oliveira and de Lancastre [6].
Of the 312 MRSA isolates examined, 306 (98%)
were typeable by the new multiplex PCR. SCCmec
type IV was the most common type (84% of the
isolates), followed by type V (6%), type I (4%)
and type II (3%). SCCmec type III was found only
in three imported isolates. The 312 isolates
belonged to nine multilocus sequence type-based
clonal complexes (CCs), with CCs 5, 8, 30 and 80
constituting 86% of the isolates (results not
shown). SCCmec typing was suitable for subtyping
multilocus sequence type CCs and spa types. Four
and ﬁve SCCmec types were found in CC5 and
CC8, respectively. The majority of isolates in CC8,
the largest complex, carried SCCmec type IV.
Six isolates were classiﬁed as NT according to
the multiplex PCR. Of these, two isolates were
also NT by the method of Oliveira and de
Lencastre [6]. These isolates may represent new
or variant SCCmec types, and their SCCmec
cassettes require further analysis. The remaining
four isolates were typeable by the method of
Oliveira and de Lancastre [6], and yielded a
corresponding band in the novel multiplex PCR;
however, either bands from other SCCmec types
were also obtained, or the SCCmec type was not
conﬁrmed by the further conﬁrmatory PCRs.
These isolates might carry new recombinant
cassettes and require further study.
Of 143 MRSA isolates recorded during 2003
and 2004, 70% were CO-MRSA and 30% were
HA-MRSA. All SCCmec types were represented in
both categories, except for SCCmec type V, which
was detected only among the CO-MRSA isolates.
SCCmec type IV was found in 86% of the CO-
MRSA isolates and in 84% of the HA-MRSA
isolates. Based on these ﬁndings, SCCmec typing
is not useful for discriminating between CO-
MRSA and HA-MRSA in Copenhagen, since
SCCmec type IV predominated among both com-
munity and hospital isolates.
Isolates representing known, pandemic, inter-
national MRSA clones [9] were identiﬁed in the
MRSA collection. These included ten isolates of
ST5-MRSA-II (the New York ⁄ Japan clone) and
nine isolates of ST5-MRSA-IV (the Paediatric
clone). There were three isolates of ST239-
MRSA-III (the Brazilian or Hungarian clone; the
SCCmec PCR does not differentiate between
SCCmec type III and IIIA). Two isolates might
correspond to the Iberian clone (ST247-MRSA-I;
SCCmec types I and IA are not distinguished by
the multiplex PCR), and the Oceanian clone was
represented by 38 isolates of ST30-MRSA-IV,
spa type t019. The ST30 isolates were typically
imported and caused small outbreaks in private
households.
The SCCmec multiplex PCR developed by
Oliveira and de Lencastre [6] can be used to
differentiate among SCCmec types I–IV [6]. The
PCR described in the present study has the
advantage of detecting type V, thereby reducing
the number of NT isolates and mistyping of type
V as type III. Zhang et al. [10] have described a
Table 1. Primers used in the multi-
plex SCCmec PCR and the resulting
gel band patterns of SCCmec types
I–V
Name Primer sequence (5¢ ﬁ 3¢) Length Target
SCCmec type
I II III IV V
b ATTGCCTTGATAATAGCCYTCTa 937 bp ccrA2-B X X
a3 TAAAGGCATCAATGCACAAACACTa
ccrCF CGTCTATTACAAGATGTTAAGGATAATb 518 bp ccrC X X
ccrCR CCTTTATAGACTGGATTATTCAAAATATb
1272F1 GCCACTCATAACATATGGAAc 415 bp IS1272 X X
1272R1 CATCCGAGTGAAACCCAAAc
5RmecA TATACCAAACCCGACAACTACc 359 bp mecA–IS431 X
5R431 CGGCTACAGTGATAACATCCc
aIto et al. [11].
bIto et al. [12].
cThis study.
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Fig. 1. Examples of PCR ampliﬁcation products obtained
with SCCmec types I–V. Lanes on the left and right of the
gel contain 100-bp ladder molecular size markers.
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nine-gene multiplex PCR that contains one primer
set for each of the main types I, II, III and V, and
one primer set for each of subtypes IVa, b, c and
d. Thus, most of the common type IV subtypes
were discriminated, but new subtypes might be
missed. The new multiplex PCR described in the
present study identiﬁed SCCmec types for 98% of
the predominantly CO-MRSA isolates investi-
gated, and adds further information to the results
obtained by determination of MLST and spa types.
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